SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-008380
Filing Date
2023-05-08
Accepted
2023-05-08 07:15:26
Documents
42
Period of Report
2023-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20230508x8k.htm   iXBRL 8-K 49135
2 EX-99.1 acrs-20230508xex99d1.htm EX-99.1 135324
3 EX-99.2 acrs-20230508xex99d2.htm EX-99.2 39926
4 GRAPHIC acrs-20230508xex99d1001.jpg GRAPHIC 13042
5 GRAPHIC acrs-20230508xex99d2g001.jpg GRAPHIC 141743
6 GRAPHIC acrs-20230508xex99d2g002.jpg GRAPHIC 339959
7 GRAPHIC acrs-20230508xex99d2g003.jpg GRAPHIC 125845
8 GRAPHIC acrs-20230508xex99d2g004.jpg GRAPHIC 147574
9 GRAPHIC acrs-20230508xex99d2g005.jpg GRAPHIC 150535
10 GRAPHIC acrs-20230508xex99d2g006.jpg GRAPHIC 217968
11 GRAPHIC acrs-20230508xex99d2g007.jpg GRAPHIC 152957
12 GRAPHIC acrs-20230508xex99d2g008.jpg GRAPHIC 126990
13 GRAPHIC acrs-20230508xex99d2g009.jpg GRAPHIC 147386
14 GRAPHIC acrs-20230508xex99d2g010.jpg GRAPHIC 117549
15 GRAPHIC acrs-20230508xex99d2g011.jpg GRAPHIC 166593
16 GRAPHIC acrs-20230508xex99d2g012.jpg GRAPHIC 190593
17 GRAPHIC acrs-20230508xex99d2g013.jpg GRAPHIC 157772
18 GRAPHIC acrs-20230508xex99d2g014.jpg GRAPHIC 149488
19 GRAPHIC acrs-20230508xex99d2g015.jpg GRAPHIC 160223
20 GRAPHIC acrs-20230508xex99d2g016.jpg GRAPHIC 233695
21 GRAPHIC acrs-20230508xex99d2g017.jpg GRAPHIC 150455
22 GRAPHIC acrs-20230508xex99d2g018.jpg GRAPHIC 166297
23 GRAPHIC acrs-20230508xex99d2g019.jpg GRAPHIC 174595
24 GRAPHIC acrs-20230508xex99d2g020.jpg GRAPHIC 180244
25 GRAPHIC acrs-20230508xex99d2g021.jpg GRAPHIC 190579
26 GRAPHIC acrs-20230508xex99d2g022.jpg GRAPHIC 163387
27 GRAPHIC acrs-20230508xex99d2g023.jpg GRAPHIC 158724
28 GRAPHIC acrs-20230508xex99d2g024.jpg GRAPHIC 157182
29 GRAPHIC acrs-20230508xex99d2g025.jpg GRAPHIC 159865
30 GRAPHIC acrs-20230508xex99d2g026.jpg GRAPHIC 130527
  Complete submission text file 0001558370-23-008380.txt   6481196

Data Files

Seq Description Document Type Size
31 EX-101.SCH acrs-20230508.xsd EX-101.SCH 3251
32 EX-101.LAB acrs-20230508_lab.xml EX-101.LAB 630
33 EX-101.PRE acrs-20230508_pre.xml EX-101.PRE 10567
36 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20230508x8k_htm.xml XML 4792
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 23895837
SIC: 2834 Pharmaceutical Preparations